Research Article

The Role of Red Blood Cell Distribution Width in the Severity and Prognosis of Community-Acquired Pneumonia

Table 3

Data characteristic between survival group and nonsurvival group.

Survival groupNonsurvival group value

Age (years)55.1 ± 18.274.4 ± 12.20.000
Smoker, n (%)1143 (37.0)89 (50.0)0.000
Drinker, n (%)674 (21.8)41 (23.0)0.693

Pulmonary comorbidities, n (%)
Bronchial asthma116 (3.7)5 (2.8)0.021
COPD282 (9.1)30 (16.9)0.001
Bronchiectasis77 (2.5)4 (2.2)0.843
Old pulmonary tuberculosis127 (4.1)12 (6.7)0.089
Interstitial lung disease34 (1.1)3 (1.7)0.470

Extrapulmonary diseases, n (%)
Heart failure79 (2.5)29 (16.3)0.000
Liver disease346 (11.2)24 (13.5)0.341
Renal disease109 (3.5)33 (18.5)0.000
Hypertension653 (21.1)59 (33.1)0.000
Diabetes361 (23.6)42 (11.6)0.000
Cerebrovascular disease381 (12.3)84 (47.0)0.000
Coronary heart disease393 (12.7)38 (21.3)0.001
Tumor96 (3.1)18 (10.1)0.000
Urinary tract infection208 (6.7)11 (6.2)0.783
Hyperthyroidism22 (0.7)1 (0.6)0.882

Auxiliary examination
Pleural effusion, n (%)637 (20.6)82 (46.1)0.000
Multiple pulmonary lobe infiltration, n (%)1709 (52.2)125 (71.0)0.000
pH7.423 ± 0.1047.471 ± 1.4140.190
PaO2 (mmHg)69.955 ± 16.49859.487 ± 20.9760.000
PaCO2 (mmHg)37.156 ± 7.39837.273 ± 14.4820.750
WBC (109/L)8.904 ± 12.20811.782 ± 6.6570.000
PLT (109/L)235.509 ± 88.709212.662 ± 88.7090.001
RDW (%)12.918 ± 1.40914.184 ± 1.7210.000
HGB (g/L)136.648 ± 14.581133.529 ± 19.4620.007
DDP (μg/L)1.586 ± 5.8185.014 ± 10.1090.000
FIB (g/L)4.507 ± 1.7594.364 ± 1.6990.307
ALB (g/L)37.517 ± 5.47229.516 ± 5.5330.000
BUN (mmol/L)5.330 ± 8.90510.918 ± 7.5020.000
PCT (ng/L)0.7878 ± 4.2115.3863 ± 13.9700.000
CRP (mg/L)61.523 ± 78.174142.611 ± 112.9610.000

CURB-65, n (%)0.000
01877 (60.5)12 (6.7)
1895 (28.9)55 (30.9)
2284 (9.2)64 (36.0)
342 (1.4)40 (22.5)
42 (0.1)7 (3.9)
500

PSI, n (%)0.000
I1090 (35.2)3 (1.7)
II902 (29.1)5 (2.8)
III635 (20.5)10 (5.6)
IV408 (13.2)91 (51.1)
V65 (2.1)69 (38.8)